References
- The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977–86.
- Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M: Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non–insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995; 28: 103–117.
- Klein R, Klein BE, Moss SE, Davis MD, DeMets DL: Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy. JAMA 1988; 260: 2864–2871.
- Kuusisto J, Mykkanen L, Pyorala K, Laakso M: NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 1994; 43: 960–967.
- American Diabetes Association: Position statement: standards of medical care for patients with diabetes mellitus. Diabetes Care 1997; 20 (Suppl 1): S5–S13.
- Weiner J, Parente S, Garnick D, Fowles J, Lawthers AG, Palmer RH: Variation in office-based quality: a claims-based profile of care provided to Medicare patients with diabetes. JAMA 1995; 273: 1503–1508.
- Watts NB, Spanheimer RG, DiGirolamo M, Gebhart SS, Musey VC, Siddiq YK, Phillips LS: Prediction of glucose response to weight loss in patients with non-insulin-dependent diabetes mellitus. Arch Intern Med 1990; 150: 803–806.
- Schneider SH, Khachadurian AK, Amorosa LF, Clemow L, Ruderman NB: Ten-year experience with an exercise-based outpatient lifestyle modification program in the treatment of diabetes mellitus. Diabetes Care 1992; 15: 1800–1810.
- United Kingdom Prospective Diabetes Study (UKPDS): 13: relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non–insulin-dependent diabetes followed for 3 years. BMJ 1995; 310: 83–88.
- DeFronzo RA, Goodman A: Efficacy of metformin in patients with non–insulin-dependent diabetes mellitus: the Multicenter Metformin Study Group. N Engl J Med 1995; 333: 541–549.
- Chiasson JL, Josse RG, Hunt JA, Palmasson C, Rodger NW, Ross SA, Ryan EA, Tan MH, Wolever TM: The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus: a multicenter controlled clinical trial. Ann Intern Med 1994; 121: 928–935.
- Iwamoto Y, Kuzuya T, Matsuda A, Awata T, Kumakura S, Inooka G, Shiraishi I: Effect of new oral antidiabetic agent CS-045 on glucose tolerance and insulin secretion in patients with NIDDM. Diabetes Care 1991; 14: 1083–1086.
- American Diabetes Association: Consensus statement: the pharmacological treatment of hyperglycemia in NIDDM. Diabetes Care 1995; 18: 510–518.
- Pugh JA, Wagner ML, Sawyer J, Ramirez G, Tuley M, Friedberg SJ: Is combination sulfonylurea and insulin therapy useful in NIDDM patients? A metaanalysis. Diabetes Care 1992; 15: 953–959.